James Altunkaya
Colleges
James Altunkaya
NIHR Doctoral Research Fellow
James is a NIHR Doctoral Research Fellow in the Health Economics Research Centre (HERC) at Oxford Population Health. He aims to provide economic evidence regarding the role of precision medicine in prediabetes.
For his DPhil, he is building and validating a new economic model of prediabetes and its consequences. This combines data from several clinical trials and cohort studies to predict individual patients’ long-term health outcomes and costs. This will allow s to understand the cost-effectiveness of early precision interventions targeted to specific prediabetes patients.
He has joined HERC in 2019 as a researcher in health economics, and prior to this held a NIHR Research Methods Fellowship at the Centre for Health Economics at the University of York. There, he was a member of the NICE academic evidence review group, critiquing the economic case for introducing new pharmaceuticals and medical devices into the NHS.
He holds a MSc in Public Health (Health Economics) from the London School of Hygiene and Tropical Medicine, and a BA in Philosophy, Politics and Economics from the University of Oxford.
Recent publications
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes.
Journal article
Zhao T. et al, (2024), Appl Health Econ Health Policy, 22, 861 - 869
Examining the Impact of Structural Uncertainty Across 10 Type 2 Diabetes Models: Results From the 2022 Mount Hood Challenge.
Journal article
Altunkaya J. et al, (2024), Value Health, 27, 1338 - 1347
Associations between body mass index and hospital resource use in patients hospitalised for COVID-19 in England: A community-based cohort study
Journal article
Altunkaya J. et al, (2024), The Lancet Diabetes and Endocrinology
Potential Value of Identifying Type 2 Diabetes Subgroups for Guiding Intensive Treatment: A Comparison of Novel Data-Driven Clustering With Risk-Driven Subgroups.
Journal article
Li X. et al, (2023), Diabetes Care, 46, 1395 - 1403
THE POTENTIAL VALUE OF IDENTIFYING TYPE 2 DIABETES SUBGROUPS IN THE CPRD COHORT FOR GUIDING INTENSIVE TREATMENT: A HTX STUDY COMPARING NOVEL DATA-DRIVEN CLUSTERING TO TRADITIONAL RISK-DRIVEN SUBGROUPS
Conference paper
Li X. et al, (2023), VALUE IN HEALTH, 26, S173 - S174

